XBI

3 Biotech Stock ETFs to Buy For Further Upside In 2021

Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.

7 Biotech ETFs to Buy Now For Covid-19 And Beyond

Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

3 Healthcare Stocks to Buy This Year

The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.

First-Mover Advantage Will Benefit Amarin Stock More Than You Think

There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.

3 Top Drug Stocks to Own In 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

4 Top Stock Trades for Friday: MU, Biotech, Bitcoin

Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.

Hexo Stock Is Down — But Not Out

HEXO stock is down 50% since the end of April. But inside this support zone, the bulls can mount a 20% rally if headlines cooperate.

7 Biotech ETFs That Should Remain Healthy

The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.

7 of the Best SPDR ETFs — Besides SPY and GLD

SPDR ETFs span an array of asset classes, including stocks, bond, commodities and real estate, among others. Here are 7 of the best ETFs to buy from SPDR.

Nasdaq Today: iQiyi Surges on Award; Intel, Cisco Struggle

Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.

IBB is up Over 5%, But the Market May Retest its Lows

This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

7 Biotech ETFs to Consider for 2019

Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.

10 Best ETFs for 2018: Still a Close Race at the Head of the Pack

As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.

10 Best ETFs for 2018: Biotechs Top the Charts at the Midpoint

As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.

Biotech ETFs Are the Best Way to Play the Recovering Sector

The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.

10 Best ETFs for 2018: A Tumultuous First Quarter

While some of the contenders have been gravitating toward the top or bottom, it's still very much anyone's game in the Best ETFs for 2018 contest.

3 Bullish Options Trades to Buy the Weakness

A phase of weakness has hit Wall Street, but the dip could be a buy. Here are three bullish options trades to consider in V, BIDU and XBI.

3 Ways to Profit from the Market Panic

On Friday, volatility went up while the stocks mostly went down. Looking to cash in on the movement? Try these options for XBI, XLE and EEM.

10 Best ETFs for 2018: Funds at the Starting Line

Which funds are going to kick the competition to the curb this year? We have 10 experts who think they know the best ETFs for 2018.